On April 6, Rahul Gandhi, leader of the Indian National Congress, accused the AINRC-BJP government in Puducherry of "30 per cent commission" and a "liquor license regime," as well as the manufacture of counterfeit drugs. He stated that the issue of fake medicines was not just about corruption...
adani
counterfeitdrugs
government corruption
health insurance
indian national congress
karaikal port
liquor licenses
local body elections
political allegations
public works department
puducherry
puducherry politics
rahul gandhi
statehood
temple land
women's bus travel
Puducherry, April 6 Congress leader Rahul Gandhi on Monday criticized the ruling AINRC-BJP government over alleged manufacturing of counterfeit drugs, asserting that it was not just corruption but a murderous act as spurious drugs were being distributed across the country.Addressing a rally...
ainrc-bjp
assembly elections
corruption
counterfeitdrugs
drug manufacturing
fraud
india
industrial decline
political campaign
puducherry
rahul gandhi
spurious drugs
statehood
textile industry
union territory
New Delhi, April 5 The Delhi Police has busted an organized interstate racket involved in the manufacturing and supply of spurious life-saving medicines, arresting six people and seizing counterfeit drugs worth around Rs 2 crore, an official said on Sunday.During the operation, the police also...
Puducherry, April 3 Veteran Congress leader V Narayanasamy has alleged that the cabinet led by Chief Minister N Rangasamy is under investigation in the scam involving the manufacturing and supply of counterfeit drugs to 8 states, and alleged a bribe of "Rs 40 lakh for a Resto bar license," while...
New Delhi, March 17 Fake and falsified obesity drugs could be prompting a public health concern driven by high prices, a lack of insurance, and the desire to lose weight, according to a world report article published in The Lancet journal.Author Sophie Cousins, an Australian writer and health...
cardiovascular health
counterfeitdrugs
diabetes treatment
drug safety
fda warning
glp-1 receptor agonists
mexico
mounjaro
obesity drugs
ozempic
pharmaceutical fraud
prescription drugs
public health
united states
weight loss
world health organization